Menu Search
Equities

EMvision Medical Devices Ltd

EMV:ASX

EMvision Medical Devices Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)1.93
  • Today's Change-0.005 / -0.26%
  • Shares traded53.06k
  • 1 Year change+18.40%
  • Beta1.9235
Data delayed at least 20 minutes, as of Nov 18 2024 02:16 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year EMvision Medical Devices Ltd grew revenues 62.99% from 7.09m to 11.56m while net income improved from a loss of 3.87m to a smaller loss of 2.73m.
Gross margin--
Net profit margin-23.61%
Operating margin-16.58%
Return on assets-15.38%
Return on equity-23.10%
Return on investment-20.97%
More ▼

Cash flow in AUDView more

In 2024, EMvision Medical Devices Ltd increased its cash reserves by 88.00%, or 8.71m. Cash Flow from Financing totalled 15.00m or 129.76% of revenues. In addition the company used 5.99m for operations while cash used for investing totalled 302.41k.
Cash flow per share-0.0288
Price/Cash flow per share--
Book value per share0.2168
Tangible book value per share0.2091
More ▼

Balance sheet in AUDView more

EMvision Medical Devices Ltd appears to have a strong balance sheet and has grown its cash reserves consistently over the last four years to total 18.60m.
Current ratio6.40
Quick ratio--
Total debt/total equity0.1566
Total debt/total capital0.1354
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.